Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer

BACKGROUND: Small cell lung cancer (SCLC) relapses rapidly after the initial response to chemotherapy and shows drug-resistance. This study was to investigate the efficacy and safety of cellular immunotherapy (CIT) with autologous natural killer (NK), γδT, and cytokine-induced killer (CIK) cells as...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Transl Med
Huvudupphovsmän: Ding, Xiao, Cao, He, Chen, Xiao, Jin, Haofan, Liu, Ziling, Wang, Guanjun, Cai, Lu, Li, Dan, Niu, Chao, Tian, Huimin, Yang, Lei, Zhao, Yuguang, Li, Wei, Cui, Jiuwei
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2015
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4446113/
https://ncbi.nlm.nih.gov/pubmed/25968637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-015-0514-0
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk